Texas A&M

racetrack

Biotech

GeneTx Biotherapeutics launches to take on Angelman syndrome

GeneTx will develop an antisense drug for Angelman syndrome, a genetic disorder that affects the nervous system.

Amirah Al Idrus Feb 23, 2018 10:57am

blue illustration of neurons

Celltex pairs with Texas A&M on exosome therapy for Alzheimer’s

Feb 7, 2018 6:41am

Cows in Pasture

How cows are boosting the search for an HIV vaccine

Jul 21, 2017 8:48am